All PlansAdministrativeHigh impact
Voluntary nationwide recall: Cyclobenzaprine (Unichem – August 2025)
UPMC Health Plan·Pharmacy·Pharmacy
Effective date
Aug 27, 2025
We identified it
Aug 7, 2026
Summary
Unichem Pharmaceuticals is recalling Cyclobenzaprine 10 mg lot GMML24026A due to mislabeling—bottles contain Meloxicam 7.5 mg tablets instead. Billing teams must alert patients and providers to verify affected medications and halt any related claims or billing for this lot. This is a patient safety issue requiring immediate communication across the practice.
Action Required
Immediately: (1) Billing team must flag any claims submitted for Cyclobenzaprine lot GMML24026A (NDC or lot verification required in pharmacy records). (2) Contact pharmacy and front desk staff to identify patients who received this lot and notify them to stop use and return medication. (3) Providers must be alerted to verify patient medication bottles and advise patients of potential adverse effects, especially those on NSAIDs or blood thinners. (4) Document all affected patients in EMR with recall alert. (5) Do not process claims for Cyclobenzaprine from this lot; coordinate with pharmacy for return/credit processing. Deadline: Verify inventory and patient dispensing records by end of business day. Contact Inmar at 1-877-840-5109 (M-F, 9 a.m.–5 p.m. CST) or FDA for lot verification. Failure to act may expose patients to serious adverse drug events.